Drug for treating polycystic ovarian syndrome

A technology for polycystic ovary syndrome, which is applied in the field of drugs for the treatment of polycystic ovary syndrome, can solve problems such as unsatisfactory clinical effects, sensitive side effects of drugs, and difficulty in adhering to the course of treatment, so as to reduce the burden on the liver and cause large gastrointestinal reactions. , the effect of heavy burden on the liver

Inactive Publication Date: 2013-01-30
姜红
View PDF4 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Modern medical treatment of polycystic ovary syndrome mainly uses anti-androgen (commonly used Diane 35) and artificial cycle of sex hormones and improves insulin sensitivity (metformin) treatment, while traditional Chinese medicine gynecology often only uses kidney and spleen, blood circulation and menstruation treatment Although these methods are effective, they still have ma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] The present invention will be further described below.

[0010] A medicine for treating polycystic ovary syndrome is characterized in that it is composed of an oral medicine and an enema medicine. Angelica, Chuanxiong, Danshen, Codonopsis, fried Atractylodes macrocephala, Poria cocos, Chinese yam, pinellia, tangerine peel, and magnolia officinalis. Tian 15g, Cuscuta 15g, Ligustrum lucidum 15g, Lycium barbarum 15g, Rehmannia glutinosa 10g, Angelica 15g, Chuanxiong 15g, Salvia miltiorrhiza 15g, Codonopsis 15g, Fried Atractylodes macrocephala 15g, Poria cocos 15g, Chinese yam 30g, Pinellia 15g, Tangerine peel 12g, Magnolia officinalis 15g , the enema medicine is composed of peach kernel, safflower, trigonum, cinnamon twig, eupatorium, thuja, prunella vulgaris, saponins, chuanxiong, seaweed, and kelp. The weights of the above components in each medicine are 15g peach kernel, 10g safflower, 15g trigonum, 12g cassia twig, 15g eupatorium, 15g pomegranate, 15g prunella vulgari...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a drug for treating polycystic ovarian syndrome. The drug is characterized by comprising an oral medicine and an enema medicine, wherein the oral medicine comprises 15 g of common curculigo rhizome, 10 g of epimedium, 15 g of common cnidium fruit, 15 g of medicinal morinda root, 15 g of dodder, 15 g of glossy privet fruit, 15 g of medlar, 10 g of prepared rhizome of rehmannia, 15 g of angelica, 15 g of szechwan lovage rhizome, 15 g of salvia miltiorrhiza, 15 g of dangshen, 15 g of stir-fried ovate atractylodes root, 15 g of tuckahoe, 30 g of common yam rhizome, 15 g of pinellia, 12 g of seasoned orange peel, and 15 g of officinal magnolia bark, and the enema medicine comprises 15 g of peach seed, 10 g of safflower, 15 g of common burreed tuber, 12 g of cassiabarktree twig, 15 g of trumpetweed, 15 g of speranskia tuberculata, 15 g of common selfheal spike, 15 g of Chinese honeylocust spine, 15 g of szechwan lovage rhizome, 15 g of seaweed, and 15 g of kelp. According to the present invention, treatment philosophy of combination of the oral medicine and the enema medicine is adopted, and blood circulation activating, blood stasis dissipating, swelling subsiding, and stagnation eliminating are adopted to reduce intumescent ovary and thin ovarian follicle, such that ovulation easily occurs.

Description

technical field [0001] The invention relates to a Chinese herbal medicine and its administration method, in particular to a medicine for treating polycystic ovary syndrome with good curative effect and no side effect. Background technique [0002] As we all know, polycystic ovary syndrome is a relatively common endocrine and metabolic disorder in adolescents and women of childbearing age, and its incidence is about 5%-10%. and insulin resistance. It is a special disease that coexists with reproductive dysfunction and abnormal glucose metabolism. The main clinical manifestations are late menstruation, amenorrhea, infertility, ovarian enlargement and other reproductive dysfunction and metabolic abnormalities such as obesity, acne and hirsutism. Because the mechanism of its occurrence and development is still unclear, it is really a difficult disease in clinical practice. [0003] Modern medical treatment of polycystic ovary syndrome mainly uses anti-androgen (commonly used ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8945A61K36/902A61P15/00A61P15/08
Inventor 刘艳萍刘红敏王小丽
Owner 姜红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap